eli lilly glp 1 weight loss The Food and Drug Administration has approved the first oral GLP-1 drug by Lilly, called Foundayo Eli Lilly's oral GLP-1 pill

Bariatric surgeons : Patients who dont qualify for surgery or prefer non-surgical options can be referred to you

The weight loss from these medications is substantial

Its use has been associated with improved glycemic control in patients with diabetes, reducing hypoglycemic events and hospitalizations independent of insulin use [4]

Studies indicate that participants can lose between 15 to 20 percent of their body weight over 72 weeks

Ecnoglutide's biased GLP-1 signaling represents a scientifically novel approach, and SLIMMER Phase 3 data (15.4% weight loss at 48 weeks) are comparable to semaglutide's STEP 1 results (14.9% at 68 weeks)

Dr Tan shares some insights, plus what you can do to manage your weight sustainably